Interestingly, it was shown that the cannabinoid receptor 2 (CB2) was overexpressed in patients with non-small cell lung cancer (NSCLC) and tumor growth and lung metastasis was remarkably inhibited by CB2 agonists [9]. The gene discussed is CNR2; the disease is non-small cell lung carcinoma.